A recent small study (50 patients) in premenopausal patients (<40 years old) with early breast cancer who received chemotherapy and co-treatment with GnRHa triptorelin reported that AMH decreased to nearly undetectable levels after chemotherapy and recovered after 12 months. This evidence concerns the gene AMH and breast cancer.